Restarting a GLP-1 After a Break: How to Avoid a Rough Restart

Breaks in GLP-1 treatment happen — a supply gap, an insurance lapse, a cost stretch, a pregnancy, a planned pause. The mistake that makes restarts miserable is assuming you can jump straight back in at the dose you left off. Often you can’t, and here’s why.

Why a break resets more than your appetite

GLP-1s have a long half-life (about 7 days for semaglutide), so a short delay of a day or two barely registers — that’s the everyday missed-dose situation, with catch-up windows built into each label.

A longer break is different. After roughly two or more missed weeks, the medication has largely cleared your system, and two things reset:

1. Appetite comes back. Hunger and food noise return, usually within weeks — often the first thing people notice.
2. GI tolerance resets. This is the one people underestimate. The tolerance you built through titration fades. Restarting at your old high dose can reproduce the worst nausea of your early weeks — or worse. Your stomach has, in effect, forgotten.

The safe way to restart

Because of that tolerance reset, restarting after a meaningful gap is a prescriber decision, not a fridge decision. Depending on how long the break was, your prescriber may:

• Have you resume at your previous dose (for shorter gaps where tolerance likely held), or
• Re-titrate from a lower dose, climbing back up — the standard move after longer breaks. The major labels explicitly raise restarting the escalation schedule after multiple missed doses.

The re-titration can feel frustrating (“I already earned this dose!”), but it’s the difference between a manageable restart and a week of vomiting.

What the labels actually say about gaps

The prescribing information gives concrete anchors, and they’re stricter than most people expect:

• Wegovy: after more than 2 consecutive missed weekly doses, resume as scheduled or restart the escalation schedule — prescriber’s call, weighing how rough your original titration was.
• Saxenda (daily liraglutide): after more than 3 days off, the label says to restart at 0.6 mg and re-titrate. Three days — which tells you how quickly GI tolerance fades when a medication clears fast.
• Zepbound / Mounjaro: the label’s missed-dose window is 4 days; beyond patterned misses, restart dosing after a longer break is individualized — prescribers commonly drop back one or more titration steps after a month or more off.

If your break is measured in months, expect to be treated as closer to a new start than a resume — and that’s protective, not punitive.

Will it work again after a break?

Yes — this worry is common and the evidence is reassuring. The medication’s mechanism doesn’t wear out from interruption: appetite suppression and weight response return once therapeutic levels rebuild. What the research does show is what happens during the off period: in the STEP 1 extension study, participants who stopped semaglutide regained about two-thirds of their lost weight within a year — appetite physiology reasserting itself, not personal failure. That’s exactly why an unplanned gap (cost, supply) is worth closing deliberately rather than drifting: the longer the break, the more ground the rebound takes back, and the more the restart resembles starting over.

One honest caveat: some people report the subjective effect feeling gentler the second time. Usually that’s re-titration doing its job (lower dose, gentler effect — it strengthens as you climb), a higher starting weight changing the reference point, or expectations recalibrated by experience. Give the restart a full titration before judging it.

How to make it smoother

• Time it well. Restart when you can afford a few potentially rough days — not the night before a big event or trip.
• Reinstate the food habits first. Small, low-fat meals; eat slowly; hydrate. The nausea playbook matters most in the restart window.
• Have anti-nausea options ready if your previous start was hard — ask your prescriber in advance.
• Expect the appetite swing. Weight may have drifted up during the gap; that’s physiology, not failure, and it typically responds again once you’re back on and re-titrated.

Why the gap itself is worth recording

When you restart, your prescriber’s first questions are how long was the break and what dose were you on before. A dose log answers both instantly — and a documented gap also explains an appetite rebound or weight bounce that would otherwise look mysterious. “There was a three-week supply gap in April” is exactly the context that turns a confusing chart into a clear one. If your history is recorded (Glu keeps dose gaps visible on the timeline), nobody has to reconstruct it from memory.

The bottom line

A short miss is a catch-up window; a long break is a restart. Treat anything past a couple of weeks as a fresh titration conversation, reinstate the food-and-hydration habits before you inject, and time it for a few days you can afford to feel off. Done that way, a break is a detour, not a derailment.

Sources: Wegovy prescribing information (missed dose and re-initiation); Saxenda prescribing information (re-initiation after >3 days); Zepbound prescribing information (Eli Lilly); STEP 1 extension (Wilding et al., Diabetes Obes Metab 2022 — weight regain after withdrawal); FDA drug shortage database.